Cetera Trust Company N.A Takes Position in Shockwave Medical, Inc. (NASDAQ:SWAV)

Cetera Trust Company N.A bought a new stake in shares of Shockwave Medical, Inc. (NASDAQ:SWAV) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 800 shares of the company’s stock, valued at approximately $152,000.

A number of other large investors have also recently modified their holdings of the stock. Handelsbanken Fonder AB boosted its stake in shares of Shockwave Medical by 10.9% during the 4th quarter. Handelsbanken Fonder AB now owns 7,100 shares of the company’s stock valued at $1,353,000 after purchasing an additional 700 shares in the last quarter. Robbins Farley boosted its stake in shares of Shockwave Medical by 1.0% during the 4th quarter. Robbins Farley now owns 4,542 shares of the company’s stock valued at $866,000 after purchasing an additional 45 shares in the last quarter. Federated Hermes Inc. lifted its position in Shockwave Medical by 8.8% during the 4th quarter. Federated Hermes Inc. now owns 4,479 shares of the company’s stock valued at $854,000 after acquiring an additional 364 shares during the period. HealthInvest Partners AB purchased a new position in Shockwave Medical during the 4th quarter valued at about $673,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank lifted its position in Shockwave Medical by 12.7% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 8,133 shares of the company’s stock valued at $1,550,000 after acquiring an additional 917 shares during the period. Institutional investors own 95.35% of the company’s stock.

Shockwave Medical Stock Down 0.1 %

Shares of Shockwave Medical stock opened at $328.60 on Tuesday. The company has a debt-to-equity ratio of 1.09, a quick ratio of 10.73 and a current ratio of 11.76. The stock has a market capitalization of $12.29 billion, a PE ratio of 84.91, a price-to-earnings-growth ratio of 2.44 and a beta of 0.92. Shockwave Medical, Inc. has a 52-week low of $157.00 and a 52-week high of $331.58. The company has a 50-day simple moving average of $287.78 and a two-hundred day simple moving average of $230.12.

Shockwave Medical (NASDAQ:SWAV) last issued its earnings results on Thursday, February 15th. The company reported $1.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.92 by $0.24. Shockwave Medical had a net margin of 20.17% and a return on equity of 23.97%. The business had revenue of $202.98 million during the quarter, compared to analysts’ expectations of $199.43 million. During the same period in the previous year, the company earned $3.71 earnings per share. The business’s revenue for the quarter was up 41.0% compared to the same quarter last year. On average, analysts anticipate that Shockwave Medical, Inc. will post 4.94 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

SWAV has been the subject of a number of recent research reports. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a $335.00 price target (up from $270.00) on shares of Shockwave Medical in a research report on Monday, April 8th. Canaccord Genuity Group reissued a “hold” rating and set a $335.00 price target (up from $263.00) on shares of Shockwave Medical in a research report on Friday, April 5th. Needham & Company LLC reissued a “hold” rating on shares of Shockwave Medical in a research report on Friday, April 5th. CL King reissued a “neutral” rating on shares of Shockwave Medical in a research report on Monday, April 8th. Finally, TheStreet raised shares of Shockwave Medical from a “c+” rating to a “b” rating in a research report on Thursday, February 15th. Ten investment analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Shockwave Medical has an average rating of “Hold” and a consensus target price of $309.11.

Insider Transactions at Shockwave Medical

In other news, CFO Dan Puckett sold 3,406 shares of Shockwave Medical stock in a transaction that occurred on Thursday, February 1st. The shares were sold at an average price of $229.76, for a total value of $782,562.56. Following the completion of the sale, the chief financial officer now directly owns 27,732 shares in the company, valued at $6,371,704.32. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, CFO Dan Puckett sold 3,406 shares of Shockwave Medical stock in a transaction that occurred on Thursday, February 1st. The shares were sold at an average price of $229.76, for a total value of $782,562.56. Following the completion of the sale, the chief financial officer now directly owns 27,732 shares in the company, valued at $6,371,704.32. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Isaac Zacharias sold 4,000 shares of Shockwave Medical stock in a transaction that occurred on Tuesday, March 26th. The stock was sold at an average price of $287.67, for a total transaction of $1,150,680.00. Following the completion of the sale, the insider now owns 56,818 shares of the company’s stock, valued at $16,344,834.06. The disclosure for this sale can be found here. Insiders sold 93,813 shares of company stock worth $23,762,679 over the last three months. 3.40% of the stock is currently owned by company insiders.

About Shockwave Medical

Shockwave Medical, Inc, a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels.